Fig. 9

(A) Analysis of LINC00162 siRNA and sorafenib combination effect on colony formation of B-CPAP cells. (B) Analysis of NANOG, SOX2, CD44, and CD133 expression by qRT-PCR (****p < 0.0001, ***p < 0.001, and ns = not significant).

(A) Analysis of LINC00162 siRNA and sorafenib combination effect on colony formation of B-CPAP cells. (B) Analysis of NANOG, SOX2, CD44, and CD133 expression by qRT-PCR (****p < 0.0001, ***p < 0.001, and ns = not significant).